XBI vs VIG

AXBI

BVIG

Measures won1–5VIG wins · of 6 · 5Y

$10,000 · 5Y$16,513VIG · XBI $11,536

Lowest cost0.04%VIG · $4 on $10k

Most income1.45%VIG · $145 on $10k

Smallest drop−7.9%VIG · worst fall in 1Y

Held in common3.5%XBI and VIG

State Street SPDR S&P Biotech ETF · $10.6BVanguard Dividend Appreciation ETF · $109B

+29.7%3 years · per year$21,822 · $16,797+18.9%

+2.9%5 years · per year$11,536 · $16,513+10.6%

0.35%Expense ratio$35 · $4 on $10k · lower wins0.04%

0.36%12-mo yield$36 · $145 on $10k1.45%

End-of-day Nov 13, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

5Y2 funds

#			Trend
1	BVIG	Vanguard Dividend Appreciation ETFRead Desk		0.04%	1.45%	0.0%	+16.0%	+16.3%	+18.9%	+10.6%	−7.9%	$109.1B
2	AXBI	State Street SPDR S&P Biotech ETFRead Desk		0.35%	0.36%	−0.4%	+23.6%	+32.5%	+29.7%	+2.9%	−14.9%	$10.6B

End-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

5Y2 funds

#			Trend
1	BVIG	Vanguard Dividend Appreciation ETFRead Desk		0.04%	1.45%	0.0%	+16.0%	+16.3%	+18.9%	+10.6%	−7.9%	$109.1B
2	AXBI	State Street SPDR S&P Biotech ETFRead Desk		0.35%	0.36%	−0.4%	+23.6%	+32.5%	+29.7%	+2.9%	−14.9%	$10.6B

End-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

XBI

SPDR S&P Biotech

$11,536

VIG

Vanguard Dividend Appreciation

$16,513

Loading…